Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the first sizeable Chinese firm to pursue a listing in the U.S. this year.
Featured Posts Title
China enjoys marriage boom as Beijing allows weddings in nightclubs
The real reason behind China’s fury toward Japan’s Takaichi
Here’s what coronavirus does to the body
Corona del Mar girls tennis defeats Portola for CIF-SS Division 1 title
China’s risky challenge to Japan — and the US
Japan’s New Leader Mentions Taiwan, and Tanks Her Relationship With China
Beijing’s financial sector reports remarkable progress during 14th Five-Year Plan period
Recent Posts
Takeda-backed Ascentage Pharma targets $1.8 bln valuation in US IPO
China app RedNote scrambling to accommodate 700K new users seeking TikTok alternative
It has been viewed as a possible IPO candidate in China. In recent years, it has become a de facto search engine for its 300 million-plus users looking for travel tips, anti-aging creams and …
China’s shot in the arm for markets
A look at the day ahead in European and global markets from Rae Wee After drowning for days in headlines about Donald Trump’s return to the White House, investors were delivered a bit of a…
China moves to boost languishing markets by ordering funds to invest more in shares
The Chinese government is trying to ensure that share prices on its domestic markets will rise by ordering pensions and mutual funds to invest more in domestic stock markets.
Stock market today: Asian shares are mixed after China rolls out market boosting measures
Asian shares were mixed on Thursday after China rolled out more moves to try to boost its lagging stock markets by raising confidence that prices will rise. Officials in Beijing said pension funds and …
China Steps Up Support for Country’s Stock Markets
State-owned insurers and mutual funds are expected to play a pivotal role in the process, the China Securities Regulatory Commission and the Ministry of Finance said in a press briefing.
Nissan-Honda deal faces big problems in China
If there’s one thing executives at Honda Motor and Nissan Motor need to fix first when – and if – they merge, it’s their China business. The Japanese duo’s sales have been falling for years…
China to guide billions of dollars of insurance money into stocks
China announced plans on Thursday to channel hundreds of billions of yuan annually into shares from state-owned insurers, in the authorities’ latest effort to support equity markets. Authorities will …
Chen Jing, award-winning computer scientist and blockchain expert, leaves US for China
Specialist in computational economics brings ‘dual perspective’ after returning to Beijing’s Tsinghua University as a professor.
American firms in China fearful of US-China trade turmoil at 5-yr high, survey shows
More than half of the American businesses in China, the highest level in five years, say they are concerned about a further deterioration in the bilateral relationship between the world’s two largest …
China Unicom Announces Change in Share Registrar
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks China Unicom (Hong Kong) Limited has announced a change in its share registrar and transfer office, effective …
‘They tied me to a bed’ – China sees resurgence in medicating ‘trouble-makers’
When Zhang Junjie was 17 he decided to protest outside his university about rules made by China’s government. Within days he had been admitted to a psychiatric hospital and treated for schizophrenia.
A 25% Trump tariff on China would be a ‘pressure point’, warns Ralph Lauren CEO
During his presidential campaign, Trump pitched several ways to up tariffs on other countries. Those included a 10% to 20% tariff on all foreign imports, a 60% to 100% additional tariff on Chinese …
